Report | SE Asia’s VC Funds: H2 2024 Review - Leaderboard

AI-enabled drug discovery firm Insilico Medicine files for Hong Kong IPO

AI-enabled drug discovery firm Insilico Medicine files for Hong Kong IPO

Photo: Pixabay

Hong Kong-based Insilico Medicine, a clinical-stage AI drug discovery startup, filed for an initial public offering on the local bourse on Tuesday. 

Edited by: Joymitra Rai